Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis
This study is currently recruiting participants.
Study NCT00004494 Information provided by FDA Office of Orphan Products Development
First Received: October 18, 1999 Last Updated: June 23, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sepsis
Respiratory Distress Syndrome
Additional conditions recognized in this trial
Respiratory Distress Syndrome, Adult
Syndrome
More general conditions related to this trial
Disease
Infection
Inflammation
Lung Diseases
Pathologic Processes
Respiration Disorders
Respiratory Tract Diseases
Systemic Inflammatory Response Syndrome
Interventions listed in this trial
vasoactive intestinal peptide
More general drug interventions related to this trial
Cardiovascular Agents
Central Nervous System Agents
Gastrointestinal Agents
Neuroprotective Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
FDA Office of Orphan Products Development
State University of New York
Back to top of Main Content
